| Entry |
|
|---|
| Name |
Farampator (USAN/INN);
Org 24448 |
|---|
| Formula |
C12H13N3O2
|
|---|
| Exact mass |
231.1008
|
|---|
| Mol weight |
231.25
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG03344 AMPA receptor modulator
|
|---|
| Efficacy |
Antipsychotic, AMPA receptor enhancer |
|---|
| Comment |
Treatment of schizophrenia
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG03344 AMPA receptor modulator
D04131 Farampator
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
Glutamate (ionotropic), non-NMDA
GRIA
D04131 Farampator (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 17
1 C1x C 19.8800 -16.2400
2 C1x C 19.8800 -17.6400
3 C1x C 18.6900 -18.3400
4 C1x C 17.4300 -17.6400
5 N1y N 17.4300 -16.2400
6 C1x C 18.6900 -15.5400
7 C8x C 15.0500 -17.6400
8 C8y C 15.0500 -16.2400
9 C5a C 16.2400 -15.5400
10 C8x C 13.7900 -18.3400
11 C8y C 12.6000 -17.6400
12 C8y C 12.6000 -16.2400
13 C8x C 13.7900 -15.5400
14 O5a O 16.2400 -14.1400
15 N5x N 11.2685 -15.8074
16 O2x O 10.4456 -16.9400
17 N5x N 11.2685 -18.0726
BOND 19
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 7 8 1
8 8 9 1
9 5 9 1
10 7 10 2
11 10 11 1
12 11 12 1
13 12 13 1
14 8 13 2
15 9 14 2
16 12 15 2
17 15 16 1
18 16 17 1
19 11 17 2
|
|---|
